Amgen (AMGN) Work In Process (2013 - 2017)

Amgen has reported Work In Process for 5 years, with the latest figure at $1.6 billion in Q2 2017.

• For the quarter ending Q2 2017, Work In Process changed N/A year-over-year to $1.6 billion; the trailing twelve-month figure through Jun 2017 stood at $1.6 billion (changed N/A YoY), and the FY2016 full-year result was $1.6 billion, up 5.17% from the prior year.
• Work In Process for Q2 2017 stood at $1.6 billion, up from $1.5 billion in the prior quarter.
• The five-year high for Work In Process was $2.1 billion in Q4 2013, with the low at $1.3 billion in Q2 2015.
• Average Work In Process over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2014.
• Year-over-year, Work In Process fell 28.1% in 2015 and climbed 5.17% in 2016.
• Tracing AMGN's Work In Process over 5 years: stood at $2.1 billion in 2013, then decreased by 24.85% to $1.6 billion in 2014, then slipped by 1.42% to $1.5 billion in 2015, then climbed by 5.17% to $1.6 billion in 2016, then increased by 0.62% to $1.6 billion in 2017.
• The last three Work In Process figures came in at $1.6 billion (Q2 2017), $1.5 billion (Q1 2017), and $1.6 billion (Q4 2016), per Business Quant data.

Peer Comparison